Loading…
The financing will support the company's ongoing clinical trials and operations.
DBV Technologies S.A. (DBVT) has secured up to $306.9 million in financing. The funds will be used to support the company's ongoing clinical trials and operational needs.
The total financing amount is $306.9 million. DBV Technologies has a free float of 86,310,000 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.